AN2 Therapeutics, Inc. - COM (ANTX)

Historical Portfolio Holders from Q1 2022 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
1.58 M
Holdings value Q1 2024
$5.11 M
Value change Q1 2024
-$15 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
2
Number of buys Q1 2024
1
Number of sells Q1 2024
-16
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
037326105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 1.58 M $5.11 M -$15 M $2.81 2
2023 Q4 20.4 M $418 M +$9.58 M $20.49 50
2023 Q3 19.9 M $320 M +$133 M $16.08 37
2023 Q2 11.7 M $99.9 M +$18.1 M $8.50 30
2023 Q1 9.6 M $94.8 M -$1.67 M $9.87 37
2022 Q4 9.75 M $92.9 M -$3.68 M $9.53 34
2022 Q3 9.46 M $164 M +$2.1 M $17.38 34
2022 Q2 9.29 M $71.6 M +$2.31 M $7.75 28
2022 Q1 8.95 M $134 M +$134 M $15.07 17